- Home
- TSHA vs CNOB Comparison
TSHA vs CNOB Comparison
Compare TSHA & CNOB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSHA
- CNOB
- Stock Information
- Founded
- TSHA 2019
- CNOB 1982
- Country
- TSHA United States
- CNOB United States
- Employees
- TSHA N/A
- CNOB N/A
- Industry
- TSHA Biotechnology: Pharmaceutical Preparations
- CNOB Major Banks
- Sector
- TSHA Health Care
- CNOB Finance
- Exchange
- TSHA Nasdaq
- CNOB Nasdaq
- Market Cap
- TSHA 1.2B
- CNOB 1.2B
- IPO Year
- TSHA 2020
- CNOB 1996
- Fundamental
- Price
- TSHA $4.87
- CNOB $25.69
- Analyst Decision
- TSHA Strong Buy
- CNOB Buy
- Analyst Count
- TSHA 9
- CNOB 2
- Target Price
- TSHA $10.22
- CNOB $29.50
- AVG Volume (30 Days)
- TSHA 3.9M
- CNOB 270.7K
- Earning Date
- TSHA 11-04-2025
- CNOB 10-30-2025
- Dividend Yield
- TSHA N/A
- CNOB 2.82%
- EPS Growth
- TSHA N/A
- CNOB N/A
- EPS
- TSHA N/A
- CNOB 1.30
- Revenue
- TSHA $6,310,000.00
- CNOB $295,956,000.00
- Revenue This Year
- TSHA N/A
- CNOB $50.31
- Revenue Next Year
- TSHA N/A
- CNOB $29.30
- P/E Ratio
- TSHA N/A
- CNOB $19.60
- Revenue Growth
- TSHA N/A
- CNOB 19.03
- 52 Week Low
- TSHA $1.05
- CNOB $20.61
- 52 Week High
- TSHA $5.51
- CNOB $28.47
- Technical
- Relative Strength Index (RSI)
- TSHA 62.34
- CNOB 64.13
- Support Level
- TSHA $3.92
- CNOB $23.28
- Resistance Level
- TSHA $4.34
- CNOB $24.59
- Average True Range (ATR)
- TSHA 0.30
- CNOB 0.63
- MACD
- TSHA 0.06
- CNOB 0.19
- Stochastic Oscillator
- TSHA 98.33
- CNOB 98.80
About TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.
About CNOB ConnectOne Bancorp Inc.
ConnectOne Bancorp Inc is a community-based, full-service New Jersey-chartered commercial bank. Substantially all loans are secured with various types of collateral, including business assets, consumer assets and commercial/residential real estate. Each borrower's ability to repay its loans is dependent on the conversion of assets, cash flows generated from the borrowers' business, real estate rental and consumer wages.